A new Ebola vaccine has proven that it is 100 percent effective against the disease on human trials, which is groundbreaking news.
However, the vaccine is not approved yet, but there is a 300,000 stockpile that has been created just in case there is another outbreak.
The fight for finding a cure for the virus has been going strong since 1976, with the first outbreak in Zaire. Now, right at the tail end of 2016, we can rest easy knowing the new vaccine shows promising results and will most likely be approved for widespread vaccinations in case of an emergency.
The vaccine was seriously needed after the last outbreak claimed the lives of over 11,000 people.
Though the new vaccine seems like a step in the right direction, there are a few setbacks. It only protects against one of the two most common strains of Ebola, and there are some side effects that include joint pain and headaches. There is also a chance that the vaccine will not give long-lasting protection.
Tests done in monkeys showed that if they were vaccinated a week before being exposed to the Ebola virus, they would be protected, and some of monkeys who were vaccinate the same day as being affected by Ebola were also protected.
We’ll have to wait and see if the vaccine gets approved for widespread use in 2017.
You Might Also Like